All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
ELV / Elevance Health, Inc.
|
|
|
|
|
|
|
|
EHTH / eHealth, Inc.
|
|
|
|
|
|
|
|
GWP / GW Pharmaceuticals plc
|
|
|
|
|
|
|
|
/ Achaogen Inc
|
|
|
|
|
|
|
|
PBYI / Puma Biotechnology, Inc.
|
|
|
|
|
|
|
|
XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
918194101 / VCA Inc.
|
|
|
|
|
|
|
|
IRWD / Ironwood Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
RARX / Ra Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
DPLO / Diplomat Pharmacy, Inc.
|
|
|
|
|
|
|
|
ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
IRTC / iRhythm Technologies, Inc.
|
|
|
|
|
|
|
|
US0153511094 / Alexion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BOLD / Boundless Bio, Inc.
|
|
|
|
|
|
|
|
NSTG / NanoString Technologies, Inc.
|
|
|
|
|
|
|
|
CMRX / Chimerix, Inc.
|
|
|
|
|
|
|
|
INCY / Incyte Corporation
|
|
|
|
|
|
|
|
PRQR / ProQR Therapeutics N.V.
|
|
|
|
|
|
|
|
SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
WVE / Wave Life Sciences Ltd.
|
|
|
|
|
|
|
|
BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
04269XAA3 / Array BioPharma Inc. Bonds 3.0% 6/1/2020
|
|
|
|
|
|
|
|
SGEN / Seagen Inc
|
|
|
|
|
|
|
|
FBT / First Trust Exchange-Traded Fund - First Trust NYSE Arca Biotechnology Index Fund
|
|
|
|
|
|
|
|
ESRX / Express Scripts Holding Co.
|
|
|
|
|
|
|
|
SPNC / Spectranetics Corp. (The)
|
|
|
|
|
|
|
|
IBB / iShares Trust - iShares Biotechnology ETF
|
|
|
|
|
|
|
|
MOH / Molina Healthcare, Inc.
|
|
|
|
|
|
|
|
/ Array BioPharma, Inc.
|
|
|
|
|
|
|
|
US29266S3040 / Endologix, Inc.
|
|
|
|
|
|
|
|
CTMX / CytomX Therapeutics, Inc.
|
|
|
|
|
|
|
|
PTHN / Patheon N.V.
|
|
|
|
|
|
|
|
ITCI / Intra-Cellular Therapies, Inc.
|
|
|
|
|
|
|
|
/ Oxford Immunotec Global PLC
|
|
|
|
|
|
|
|
CSLT / Castlight Health Inc - Class B
|
|
|
|
|
|
|
|
NVRO / Nevro Corp.
|
|
|
|
|
|
|
|
ARIA / ARIAD Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
ALDR / Alder BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
NDRM / NeuroDerm Ltd.
|
|
|
|
|
|
|
|
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
MODN / Model N, Inc.
|
|
|
|
|
|
|
|
SYRS / Syros Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
0PP / Portola Pharmaceuticals Inc
|
|
|
|
|
|
|
|
GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
UNH / UnitedHealth Group Incorporated
|
|
|
|
|
|
|
|
CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
HUM / Humana Inc.
|
|
|
|
|
|
|
|
PRTA / Prothena Corporation plc
|
|
|
|
|
|
|
|
CNC / Centene Corporation
|
|
|
|
|
|
|
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
DVAX / Dynavax Technologies Corporation
|
|
|
|
|
|
|
|
PEN / Penumbra, Inc.
|
|
|
|
|
|
|
|
DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
CRL / Charles River Laboratories International, Inc.
|
|
|
|
|
|
|
|
BSX / Boston Scientific Corporation
|
|
|
|
|
|
|
|
NVTA / Invitae Corporation
|
|
|
|
|
|
|
|
ATRA / Atara Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
FATE / Fate Therapeutics, Inc.
|
|
|
|
|
|
|
|